Page 4 - Pharma Sector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sandip Sabharwal discusses the pharma sector, IndiGo stock, PSU banks, hospital stocks, consumer sector, and the performance of ABFRL and Trent. Sabharwal says Aurobindo Pharma has some active accounting and the injectable facility issue may drag on some more time. Hindalco has been on a tear ex of this sell-off which has happened now, despite the fact that the entire aluminium, copper and the metal basket has gone nowhere.

Mukhtar Abbas Naqvi expressed admiration for the collective commitment of the government, society, and medical fraternity in tackling the Covid-19 pandemic. He credited Prime Minister Narendra Modi's alertness in ensuring preparedness and quick action. Naqvi praised the government's efforts in providing quality healthcare and its philosophy of leaving no one behind.

Sumeet Bagadia of Choice Broking has chosen Cipla as his ‘Valentine's Day 2024 Pick’. Bagadia has recommended a ‘Buy’ on the pharma stock at ₹1,450 and up to ₹1,415 for a target price of ₹1,600 to ₹1,660.

The review highlighted structural reforms and digital infrastructure development as key drivers of economic growth, citing examples such as the Aarogya Setu and CoWIN apps that aided pandemic response

The government aims to offer support to pharmaceutical manufacturers to ensure the global minimum tax presents "the smallest possible burden", the Finance Ministry said on Friday, after a decree on modifications to pharma sector taxes was published, state news wire MTI reports.